Salute e Benessere

Piramal Pharma Limited Announces Results for Q4 and FY2024

Key Highlights for Q4 and FY2024 Nandini Piramal, Chairperson, Piramal Pharma Limitedsaid, " FY24 has been a strong year for the Company with all round improvement, mainly driven by our CDMO business that delivered a robust 19% YoY revenue growth. We saw significant increase in order inflows, especially for on-patent commercial manufacturing, amidst a difficult biotech funding environment. Contributions from our innovation related work and differentiated offerings also...
PR Newswire
10/05/2024

KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of…

RIYADH, Saudi Arabia, May10, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) has experienced a year of achievements across its three Centres of Excellence—Oncology, Genomics, and Transplantation.KFSH&RC's Oncology Centre of Excellence continues to lead the fight against the disease in the Kingdom. This year alone, the centre has treated 25% of all cancer cases in Saudi Arabia, achieving a 50% overall recovery rate and up to 90% recovery...
Nasdaq GlobeNewswire
10/05/2024

Vendor Neutral Archive (VNA) & PACS Market Worth $7.3 billion |…

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1255 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1255 Browse in-depth TOC on "Vendor Neutral Archive (VNA) & PACS Market" 150 - Tables 50 - Figures 320 - Pages Vendor Neutral Archive (VNA) & PACS Market Scope: VNA segment accounted for the largest share of the global Vendor Neutral Archive (VNA) & PACS market in 2023...
PR Newswire
10/05/2024

Orexo publishes prospectus and applies for admission to trading of social bonds…

For further information please contact:Nikolaj Sørensen, President and CEOFredrik Järrsten, EVP and CFOLena Wange, IR & Communications DirectorTel: +46 (0)18 780 88 00E-mail: ir@orexo.com For further information please contact:Nikolaj Sørensen, President and CEO Fredrik Järrsten, EVP and CFOLena Wange, IR & Communications Director Tel: +46 (0)18 780 88 00 E-mail:ir@orexo.com About OrexoOrexo is a Swedish pharmaceutical company with over 25 years of experience developing...
PR Newswire
10/05/2024

Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for…

Since its initial public offering, Kexing Biopharm has actualized international strategies, focusing on high clinical value, a high technical level, high international quality management and registration standards, and fast commercialization to expand its portfolio to 13 products. Paclitaxel for Injection (Albumin Bound) is Kexing Biopharm's first drug for cancer therapy. The manufacturing of the drug requires production equipment of a higher level, technical expertise of an advanced level…
PR Newswire
10/05/2024

iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

- Belrestotug + dostarlimab exceeded pre-defined efficacy criteria for clinically relevant activity observed in an interim assessment of Phase 2 GALAXIES Lung-201 - Clinically meaningful tumor reduction observed at every belrestotug + dostarlimab dose vs monotherapy - GSK to provide update on GALAXIES program at upcoming investor event in June - RA Capital and Boxer Capital led $120 million registered direct offering at $17.50, representing a premium of approximately 44% to last close…
Nasdaq GlobeNewswire
10/05/2024

iTeos Therapeutics Announces $120 Million Registered Direct Offering

-Led by existing investors RA Capital Management and Boxer Capital - Purchase price of $17.50 represents a premium of approximately 44% to last close - Further strengthens balance sheet with pro forma cash position of $715 million, extending anticipated runway through 2027 WATERTOWN, Mass. and GOSSELIES, Belgium, May10, 2024(GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of...
Nasdaq GlobeNewswire
10/05/2024

SciBase announces outcome in rights issue of units

"I am grateful for the support we have from our existing owners and also welcome our new owners to SciBase. We are in a very interesting position as we now can continue to deliver on our strategy. With our profitable growth in Germany as a base and our significant progress in the US, we are now well positioned to establish Nevisense as the new standard of care and contribute to saving lives. The US is developing according to our plans and in recent quarters we have gained several new…
PR Newswire
10/05/2024

Medical Polymer Market worth $60.5 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Medical Polymer Market" Browse in-depth TOC on "Medical Polymer Market" 341 – Tables 56 – Figures 439 – Pages Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=211635984 Medical Plastics, by type, is expected to be the most significant medical polymer market segment during the forecast period. Medical plastics are poised to maintain the most significant market share in the medical polymer market due to their...
PR Newswire
10/05/2024

Mother's Day 2024: 135th Canton Fair Celebrates Women with Unique Home Textile…

Sunvim Group Co., Ltd., a modern enterprise specializing in mid- to high-end home textile products such as towels, beddings, decorative fabrics, etc., introduces dozens of new products at the Fair. Among these is the Gold Guard series—a functional product line made from food-grade safe materials, boasting antibacterial, anti-mite, mold-proofing properties while eliminating odors and formaldehyde. The Era Bright series focuses on bamboo fiber materials, using original liquid coloring technology…
PR Newswire
10/05/2024

Momcozy Celebrates Motherhood with "Momcozy Village" Event at Babylist Beverly…

Aramyan facilitated a powerful presentation which illuminated the barriers that come between mothers and meeting their needs. After, she explored the impacts of mom guilt and led a guided meditation for participants to further explore it. The presentation was followed by a memorable group photo session symbolizing the strong connections formed. The event concluded with the distribution of specially prepared VIP gift - Momcozy Village Supply Box, leaving attendees with lasting memories and a…
PR Newswire
10/05/2024

Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to…

Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesAgreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwards Accelerates potential for development of a novel flu-COVID-19 combination product based on authorized vaccines with demonstrated efficacy and tolerability, potentially offering...
Nasdaq GlobeNewswire
10/05/2024

Invitation to attend the annual and the extraordinary shareholders' meetings of…

REGULATED INFORMATIONMay 10, 2024, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the annual and the extraordinary shareholders' meetings of the Companyto be held on June 12, 2024 The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders' meeting of the Company, to be held onWednesday, June 12, 2024 at 2:00 p...
Nasdaq GlobeNewswire
10/05/2024

WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval

The FDA approval of WGc-043 represents a significant advance in cancer treatment, offering new hope to patients with advanced EB virus-related cancers. EB virus is highly correlated with more than ten malignancies, including nasopharyngeal carcinoma (NPC), natural killer T-cell lymphoma (NKTL), gastric cancer, lung cancer, liver cancer, esophageal cancer, breast cancer, cervical cancer, and autoimmune diseases such as multiple sclerosis and systemic lupus erythematosus. These are potential…
PR Newswire
10/05/2024

DBV Technologies to Participate in Upcoming Investor Conferences

DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, today announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May. Citizens JMP Life Sciences Conference – May 13, 2024...
Nasdaq GlobeNewswire
09/05/2024

Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD…

As an act of compassionate therapy, the female donkey was administered a liposomal-CBD injection. The effect was immediate, with Miri becoming active and roaming the farm. Following the liposomal-CBD injection, the abscess in her affected foot healed, and Miri regained her ability to walk and move as she did before her laminitis developed. As an act of compassionate therapy, the female donkey was administered a liposomal-CBD injection. The effect was immediate, with Miri becoming active and...
PR Newswire
09/05/2024

The Indonesia Construction Equipment Market Sales to Reach 36,510 Units by 2029…

Indonesia Construction Equipment Market Report Scope Indonesia Construction Equipment Market Report Scope In 2023, the Indonesian government increased infrastructure development projects, including constructing airports, railway lines, roadways, highways & bridges across the country. The government invested$407 billionunder the Nation Strategic Plan; the fund was directed in 200 different PPP projects in 2023. The demand for hydraulic excavators is growing due to the rise in...
PR Newswire
09/05/2024

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to…

Research Nester concluded: "The pancreatic cancer market in North America is garner the largest revenue by the end of 2036 due to several demographic changes, including an aging population and increased incidence of obesity and diabetes. In the US, there are 37.3 million diabetics (11.3[R3] % of the population); 28.7 million are diagnosed with diabetes, including 28.5 million adults. As the population ages, there will be a higher prevalence of chronic diseases such as diabetes and obesity…
PR Newswire
09/05/2024

King Faisal Specialist Hospital & Research Centre Leading Health Sector…

Central to these achievements, King Faisal Specialist Hospital & Research Centre (KFSH&RC), renowned for its specialized care and treatments across critical fields such as oncology, cardiology, organ transplantation, and genetics has positioned itself as a leader in specialized patient care, taking the charge towards a brighter, healthier future for the Kingdom. Through its commitment to pioneering digital health initiatives, comprehensive educational programs, and novel research...
Nasdaq GlobeNewswire
09/05/2024

Veterinary Imaging Market Size Projected to Reach USD 4,306.6 Million by 2034…

The market is also propelled by advancements in imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, which provide accurate and early diagnosis of animal diseases and injuries, leading to better treatment outcomes. However, the high cost of equipment and initial investments, financing constraints, and the requirement for skilled workers pose significant challenges to the sector's growth. The market is also propelled by advancements in…
PR Newswire
09/05/2024

Household Appliances Market to Reach $983,193.41 Million, Globally, by 2035 at…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/5137 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/5137 Prime determinants of growth The growth of the household appliances market is primarily determined by several key factors. Technological advancements play a pivotal role, with innovations such as smart home integration, energy-efficient designs, and enhanced functionalities...
PR Newswire
09/05/2024

Digital X-ray Market Worth $6.6 billion | MarketsandMarkets™

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1164 Browse in-depth TOC on "Digital X-ray Market" 200 - Tables 40 - Figures 300 - Pages Digital X-ray Market Scope: Direct radiography technology segment to register a significant growth rate over the forecast period of 2024-2029. Based on the technology, the globaldigital...
PR Newswire
09/05/2024

Pharmacogenomics Market Worth $19.5 billion by 2031 -- Exclusive Report by…

Pharmacogenomics plays a pivotal role in the identification of response and non-response from an individual toward a particular drug. This helps in avoiding adverse events and optimizing drug dose. Drugs labeled with pharmacogenomic biomarkers provide information on drug exposure and clinical response variability, risk for adverse events, genotype-specific dosing, mechanisms of drug action, polymorphic drug target and disposition genes, and trial design features. Pharmacogenomic biomarkers are…
PR Newswire
09/05/2024

Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb

In the case of pelareorep, an intravenously delivered immunotherapy agent developed by Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), the case is getting stronger for it to one day become a treatment for multiple cancers, including most prominently pancreatic cancer. Near the end of 2022, the FDA granted pelareorep a Fast Track Designation for the treatment of pancreatic ductal adenocarcinoma (PDAC) after it demonstrated some optimistic results. Now Oncolytics is continuing to move its…
PR Newswire
09/05/2024
Altri  Comunicati